Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
An ongoing real-world study on the Israeli population finds that the Pfizer COVID vaccine is safe to use - minimal side effects were observed in over 800,000 people.
A new study, published in The Lancet, found that 50% of hospitalised COVID patients have at least one symptom after 12 months - with one in three of them experiencing shortness of breath.
Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.
A study by the University of Florida finds that vaccinated mothers transfer COVID antibodies to babies via breast milk - suggesting that mothers can "pass on this immunity to their babies".
The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..
Study suggests that long COVID patients are more likely to face blood-clots - even if they appeared okay, their clotting biomarkers were significantly high.
Global "vaccine nationalism" is the dominant approach to the virus so far - but according to researchers at Princeton and McGill University, this mentality increases the chances of a new variant.